Pharma Journalist -

Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, announced the closing of an…
Read More...

Innovent Biologics, Inc. jointly announced with Eli Lilly and Company (Lilly) the research results of TYVYT (sintilimab injection) ORIENT-1 study for the treatment of relapsed or…
Read More...

Celltrion Group announced positive pre-clinical results for its COVID-19 antiviral antibody treatment, with data demonstrating a 100-fold reduction in the viral load of SARS-CoV-2, the…
Read More...

Ajinomoto Bio-Pharma Services announced that it has entered into a manufacturing agreement with Humanigen, Inc., for the fill finish supply of lenzilumab, currently being studied in a…
Read More...

Roche announced the initiation of a global phase III, randomised, double-blind, multicentre study (REMDACTA) to evaluate the safety and efficacy of Actemra/RoActemra plus the…
Read More...

Almac Group has received a $288,000 grant to support a clinical study in Sub-Saharan Africa in efforts to find a treatment for Coronavirus. This was awarded from the COVID-19…
Read More...

Lonza Sales AG, through its Bioscience Division, and Sanquin Reagents B.V. have entered into a strategic partnership for the commercialization of a range of specialized reagents for…
Read More...

Bird Rock Bio, Inc., a clinical stage biopharmaceutical company, announced that the Company has filed an investigational new drug (IND) application with the U.S. Food and Drug…
Read More...

Advent Srl, an IRBM company and global leader in viral vector manufacturing, announces it has manufactured 13,000 doses of the novel Covid-19 vaccine candidate, ChAdOx1 nCoV-19 (now…
Read More...

AveXis, a Novartis company, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending…
Read More...